Ferronil

Quick links to important sections

Ferronil

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferronil

What is Ferronil? (Ferrous Carbonate)

Property Description
Active Ingredient Ferrous Carbonate (Iron (II) Carbonate)
Form Solid or liquid Oral Preparation (e.g., tablet, capsule)
Pharmacological Class Anti-anemic agent (Hematinic)
General Purpose Restoration of iron stores
Origin Synthetic/Inorganic Compound

What Type of Medicine is Ferronil?

Ferronil is the proprietary name for a medicinal product whose active constituent is Ferrous Carbonate, classified as an Anti-anemic agent (a Hematinic) and used as an Iron supplement intended to restore the body's essential mineral reserves. This classification signifies its specific application in addressing deficiencies related to blood composition, particularly in patient groups such as pregnant women.

As a therapeutic agent, Ferronil is a chemically-defined, inorganic iron compound that is synthetically prepared to provide a dependable source of the element. The formulation of ferrous salts enhances iron bioavailability and absorption, highlighting that this medicine is essential for maintaining the body's capacity to form red blood cells and transport oxygen.


Ferronil Composition: The Role of Ferrous Carbonate

The core active ingredient in Ferronil is Ferrous Carbonate, an Iron salt formulated to deliver bivalent iron (Fe2+) to the body. This medicine is administered via the oral route and is typically provided as a solid oral preparation, such as a tablet or capsule. The chemical composition confirms that the bivalent iron form possesses the necessary charge state for effective absorption by the gastrointestinal system, thereby maximizing its pharmacological availability.

Ferronil is a single-active-ingredient product, distinguishing it from multi-vitamin or combination mineral supplements. The ferrous form of iron salts possesses a high degree of bioavailability, supporting the formulation's efficiency in ensuring the body receives a readily available supply of the essential mineral.


What is the General Purpose of Ferronil?

The general purpose of Ferronil is the restoration of iron stores to support the production of hemoglobin and maintain efficient oxygen transport throughout the body. By supplying the necessary material, the medicine enables red blood cells to effectively carry oxygen from the lungs to all tissues and organs. A typical scenario for its use involves correcting low iron levels in individuals exhibiting signs of fatigue.

This action is crucial because Iron is an irreplaceable component of the metabolic machinery that supports cellular respiration and energy generation. Therefore, its focused replenishment with a dedicated Anti-anemic agent like Ferronil helps support metabolic function and overall well-being compromised by iron deficiency.

Regulatory References

  1. iron bioavailability and absorption
  2. solid oral preparation, such as a tablet or capsule

What side effects are possible with Ferronil?

Possible Side Effects and Safety Information

The safety profile for Ferronil (Ferrous Carbonate), as documented in official government labeling, is defined primarily by adverse reactions grouped under Gastrointestinal Disorders. The vast majority of documented effects are related to the digestive system and are categorized by frequency.

Officially Classified Adverse Reactions

Classification Examples of Reactions
Very Common Darkening of stools (expected, non-pathological)
Common Nausea, Vomiting, Diarrhea, Constipation, Abdominal pain/discomfort, Heartburn
Rare Hypersensitivity reactions (e.g., skin rash, pruritus)

These gastrointestinal disturbances are often documented as being more prominent at the start of therapy or when the dose is increased, reflecting a time-related safety pattern noted in regulatory texts.

Serious Safety Considerations

Official regulatory documents emphasize the serious risk of Acute Iron Overdose/Toxicity. This is highlighted as a concern for fatal poisoning, especially in young children, necessitating a prominent safety characteristic on all regulatory labels for iron-containing products.

Safety limitations also define patient groups where use is restricted or contraindicated. Ferronil should not be used in individuals with pre-existing iron overload conditions, such as hemochromatosis or hemosiderosis, or in cases of anemia not confirmed to be due to iron deficiency. This information outlines the necessary official boundaries for safe administration.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Ferronil (Ferrous Carbonate) overdose is defined by the risk of severe toxicity and the mandatory requirement for immediate medical intervention.

Documented Overdose Manifestations

Acute iron overdose is characterized initially by local corrosive effects on the gastrointestinal system, progressing to systemic involvement. Officially documented signs include severe gastrointestinal symptoms such as nausea, vomiting (which may be bloody), severe abdominal pain, and bloody diarrhea. Systemic involvement is marked by lethargy, a rapid heartbeat (tachycardia), and low blood pressure (hypotension).

Life-Threatening Outcomes and Required Action

Official regulatory sources warn that overdose can rapidly lead to life-threatening complications, including circulatory collapse (shock), metabolic acidosis, hepatic necrosis, and potential death. The FDA mandates that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.

Immediate action is required: call a doctor or poison control center immediately in case of any suspected overdose. Urgent medical attention and hospitalization are necessary for monitoring and the administration of specific treatment, which includes procedures like whole bowel irrigation and the iron-chelating antidote, Deferoxamine, to manage systemic toxicity.

Therapeutic Uses of Ferronil

Ferronil: Key Therapeutic Uses and Benefits

Ferronil, an oral iron supplement, is generally used in the therapeutic domain of addressing iron deficiency, which is a state that involves a fundamental systemic imbalance.

In clinical practice, iron preparations are applied in addressing conditions where functional stability becomes affected due to iron deficiency. This function helps address symptom clusters related to systemic imbalance, such as fatigue, weakness, and problems with concentration, which are common indications. This medicine is commonly used across conditions presenting with acute episodes of deficiency or conditions associated with acute or disruptive episodes.

It supports the patient during symptomatic periods and contributes to easing the overall symptom load by providing the necessary mineral. It assists with maintaining functional stability when iron levels are low. When symptoms become more noticeable, this supportive relief is relevant. Ferronil may assist with easing symptoms related to physical discomfort and symptoms that interfere with daily functioning.


Quick Fact: Support for Symptoms Related to Systemic Imbalance

Regulatory References

  1. NIH MedlinePlus overview of Iron Supplements

Eligibility and Restrictions for Use

Ferronil's eligibility is strictly defined by regulatory documents, determining who may use the medicine and who is prohibited. Absolute contraindications prohibit use in individuals with pre-existing iron overload conditions, such as Haemochromatosis or Hemosiderosis. It must also not be used by patients receiving repeated blood transfusions or concomitant parenteral iron therapy, nor by those with an active peptic ulcer or severe inflammatory bowel disease. Use of Ferronil requires caution in patients with a history of peptic ulcers, intestinal strictures, or swallowing difficulties, particularly older adults for solid formulations. For pediatric groups, solid oral preparations are not recommended for children under 12, and serious warnings exist regarding the risk of fatal accidental overdose in children under six years of age. Conversely, adults and pregnant or lactating women are generally considered eligible populations, with use during pregnancy often being recommended by regulatory bodies. Treatment duration is typically restricted to a maximum of three months after anaemia correction.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Regulatory documents define the interaction profile of Ferronil (Ferrous Carbonate) based primarily on pharmacokinetic interactions involving the reduction of oral bioavailability.

Formal Contraindications

Co-administration of Ferronil is strictly contraindicated with certain substances due to the risk of severe, additive effects:

  • Intravenous (IV) Iron Preparations: The combination carries a severe risk of iron overload (hemosiderosis).
  • Dimercaprol: Concurrent use is prohibited due to the risk of forming toxic complexes.

Drug and Substance Interactions Reducing Exposure

Many interactions result in significantly reduced systemic exposure of Ferronil or the co-administered drug, typically due to chelation or complex formation in the gastrointestinal tract. This necessitates mandatory timing separation rules:

  • Quinolone and Tetracycline Antibiotics: Reduction in the oral bioavailability of the antibiotic is documented, requiring separation of doses by at least two hours.
  • Levothyroxine: Iron reduces the absorption of Levothyroxine, mandating separation of administration by at least four hours.
  • Bisphosphonates and Penicillamine: Reduced absorption of these agents is documented, requiring administration separation of at least two hours.
  • Antacids: Co-administration reduces iron absorption due to decreased solubility, requiring timing constraints.

Food and Supplement Interactions

Regulatory information notes that ingestion with specific dietary components interferes with iron absorption:

  • Phytates (found in whole grains), Calcium Salts (including dairy products), and Tannins (in tea and coffee) significantly reduce the oral bioavailability of Ferronil. Conversely, Ascorbic Acid (Vitamin C) is officially documented to enhance iron absorption.

Mechanism of Action

Ferronil (Ferrous Carbonate) functions as a substrate replenishment agent, supplying essential bivalent iron ( Fe^2+) to key metabolic and biosynthetic processes. Its mechanism involves the substitution of a mineral substrate to facilitate critical biological pathways.

Facilitating Hemoglobin Biosynthesis

This domain covers the molecular interaction where absorbed Fe^2+ is transported via plasma Transferrin and delivered to bone marrow Erythroid Precursors through the Transferrin Receptor 1 (TfR1). The mechanism's core is the incorporation of iron into the Protoporphyrin Ring to synthesize Heme, thereby removing the substrate-dependent rate-limiting step in Hemoglobin (Hb) formation. This fundamental biochemical action directly contributes to the biosynthesis of the oxygen-carrying protein.

Influence on Systemic Oxygen Transport

The physiological effect resulting from the increased Hb synthesis rate is the increased concentration of functional Hb within red blood cells, which enhances the blood's capacity to transport oxygen (O2) to all tissues. The mechanism influences the physiological state of tissue hypoxia (cellular oxygen deprivation) and contributes iron as a cofactor for the machinery of mitochondrial respiration and energy generation. This systemic process defines the resulting physiological changes.

⏳ Constraints and Time-Dependent Mechanisms

The full physiological consequence of iron replenishment is constrained by the body's natural regulatory systems and biological timing. The effectiveness of the mechanism can be limited by high levels of the peptide Hepcidin (due to inflammation), which blocks iron efflux via Ferroportin. Furthermore, the final systemic effect is dependent on the multi-week timeline required for new, iron-replete red blood cells to mature and enter circulation, defining the pace of the overall mechanism.

Dosage and Administration Information

Official Administration Guidelines for Ferronil

Ferronil (deferiprone) is an oral medication with dosing schedules that vary by formulation and patient weight, and is used in adult and pediatric patients aged 3 years and older. The administration route is Oral for both tablet and oral solution forms, with a dosing frequency pattern of daily total dose divided into two or three doses per day.

Dosing and Preparation

The recommended starting oral dosage is 75 mg/kg actual body weight per day, divided into two or three daily doses. The maximum oral dosage is 99 mg/kg actual body weight per day. Doses must be accurately calculated and rounded: to the nearest 500 mg or 250 mg for tablets, or to the nearest 2.5 mL for the oral solution. For the twice-daily tablet regimen, doses should be taken with food and separated by approximately 12 hours. The three-times-daily regimens (tablet or solution) may be taken without a specific food requirement, but commencing with a lower initial dose (45 mg/kg/day) and increasing weekly is an option to minimize gastrointestinal upset.

Special Procedural Rules

Interactions with Cations: To prevent reduced absorption, an interval of at least 4 hours must be maintained between the administration of Ferronil and any drugs or supplements containing polyvalent cations (e.g., iron, aluminum, or zinc).

Monitoring: Serum ferritin concentration must be monitored every two to three months. If the level remains consistently below 500 mcg/L, temporary interruption of Ferronil therapy should be considered until serum ferritin rises back above 500 mcg/L. The absolute neutrophil count (ANC) must be measured before starting treatment and monitored weekly, and the drug must be interrupted if neutropenia (ANC < 1.5 times 10⁹/L) or infection develops.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ferronil

This section summarizes the structure and focus of the official research that has examined oral iron salts, such as Ferronil (Ferrous Carbonate), providing context for what the clinical studies monitored and what remains uncertain.


Evidence for Use in Iron Deficiency Anemia (IDA)

The foundational research for oral iron salts is based on Randomized Controlled Trials (RCTs) and Systematic Reviews and Meta-analyses, which compare the medicine against an inactive placebo or no intervention. This research primarily focused on people diagnosed with IDA, including general adults and high-risk groups like menstruating women.

Studies mainly monitored outcomes related to systemic or functional imbalance, specifically measuring key blood markers. Researchers routinely examined markers like Hemoglobin (Hb) levels and Serum Ferritin, a direct measure of the body's iron stores. Findings describe patterns observed in the studies where these blood markers were measured in the groups receiving the oral iron intervention. Research also examined patient-reported outcomes describing perceived discomfort, such as scores for general fatigue and weakness, during the study period.


Evidence for Functional and Quality-of-Life Outcomes

Beyond blood markers, research has explored the role of oral iron salts in addressing other outcomes reflecting daily functioning or activity level, particularly in people with iron deficiency who may not have fully developed anemia. Studies evaluated outcomes such as cognitive function and physical capacity. Findings were mixed across studies, with research suggesting that some measures of cognitive function, such as attention, may be associated with the intervention during the study period.


Research on Preventing Iron Deficiency During Pregnancy

The use of oral iron preparations for prophylaxis (prevention) of iron deficiency and anemia during pregnancy was evaluated in several RCTs. These studies monitored maternal hematologic outcomes, such as the rate of developing anemia, and explored infant outcomes, including birth weight. Findings describe patterns observed in the studies where the rate of maternal anemia data show patterns related to the use of the oral iron intervention. However, findings were mixed or inconsistent across different Systematic Reviews regarding reported patterns for preterm birth and mean birth weight.


What the Research Does Not Fully Address: Gaps and Uncertainties

A key limitation across the research base is that follow-up durations were limited. Most studies only observed responses over defined time intervals. Therefore, there is limited information for long-term outcomes regarding the sustained effects of oral iron on functional status or the necessity of maintaining iron supplementation over many years. Data for certain groups, such as older adults with complex health conditions, also remains insufficient.

Key Studies & References

  1. A Study of the Effects of Latent Iron Deficiency on Measures of Cognition: A Pilot Randomised Controlled Trial of Iron Supplementation in Young Women
  2. Antenatal iron supplementation - World Health Organization (WHO)

Frequently Asked Questions (FAQ)

Common questions about Ferronil (FAQ)

Q: Is Ferronil considered a long-term treatment or just for a short period?

Regulatory documents indicate that treatment with Ferronil is typically restricted to a short period. The maximum duration cited in official guidelines is generally three months following the correction of anaemia and replenishment of iron stores.

Q: How quickly can a person expect to see any changes after starting Ferronil?

Official information indicates that iron therapy may take up to four weeks to achieve its full effect. However, clinical experience suggests some individuals may notice symptomatic changes after about one week of consistent use.

Q: Is it normal to feel a bit nauseous when first starting Ferronil?

Nausea is a very common side effect reported for oral iron supplements like Ferronil. According to official product information, gastrointestinal upset is often more prominent when treatment is first started or if the dosage is increased.

Q: If I miss a day of taking Ferronil, should I adjust my schedule?

Regulatory guidance advises that a missed dose may be taken when remembered, but if it is nearly time for the next dose, the missed dose should be skipped. Patients should not take a double dose to make up for a missed one.

Q: Is there any evidence about Ferronil being used by older adults (seniors)?

Studies and regulatory documents note that extra caution may be required when Ferronil is used by older adults. Research evidence related to the safety and efficacy of iron supplementation specifically for seniors with complex health conditions is sometimes considered limited.

Q: What does the research say about the duration of treatment with Ferronil?

Research and regulatory guidance both emphasize that treatment is typically time-limited. Official guidance suggests that treatment is generally continued until the condition is corrected and iron stores are adequate, usually not exceeding a maximum of three months after the correction of anaemia.

Q: Can Ferronil cause skin changes, like rashes or increased sensitivity to the sun?

Official adverse reaction lists mention that a skin rash, hives, or itching can occur as signs of a rare, but potentially serious, allergic or hypersensitivity reaction. Increased sensitivity to the sun is not typically documented as a common side effect.

Q: Is Ferronil primarily used for treatment or is it sometimes used to prevent something?

Ferronil is indicated for both purposes. It is used for the treatment of existing iron deficiency and is also used for the prevention (prophylaxis) of iron deficiency anemia in high-risk groups, such as during pregnancy.

Q: What does the patient information leaflet say about stopping the use of Ferronil?

Regulatory information indicates that the medication may need to be interrupted or stopped for several clinical reasons. This includes if certain monitoring markers (like ferritin or a type of white blood cell count) drop too low, if a serious infection develops, or once the treatment's maximum duration is reached.

Q: Is Ferronil classified as a prescription-only medicine or available over-the-counter?

Oral iron supplements like Ferronil are widely available over-the-counter (OTC) in pharmacies and stores without a prescription. However, they can also be obtained with a prescription, depending on the dosage and formulation.

Q: Do the official safety classifications for Ferronil include warnings about liver function?

Official drug labeling cautions that use of iron may necessitate specialized oversight in patients with serious impairment of liver function. This is noted as a necessary precaution in regulatory documents.

Q: Can Ferronil affect a person's mood or mental clarity?

While regulatory documents do not list mood changes as a common side effect, clinical studies have evaluated the effect of iron supplementation. This research explored its potential impact on certain cognitive functions, such as attention and concentration.

Q: What does the evidence suggest about Ferronil's use in children or adolescents?

Official guidance notes that use of this medicine in children may necessitate consultation with a physician. Furthermore, solid oral forms may be contraindicated below a certain age due to safety risks. Clinical research has included study subjects aged six years and older.

Q: Is there a known link between Ferronil and changes in appetite?

A change in appetite is not listed among the commonly reported side effects of oral iron supplements. However, loss of appetite may be listed in regulatory documents as a symptom associated with a potential overdose or serious complication.

Q: What are the official guidelines regarding the use of Ferronil during periods of illness?

Regulatory documents advise that use may be cautioned in patients with underlying infectious conditions. Specifically, regulatory guidance indicates that the medicine may need to be interrupted if monitoring suggests a serious infection has developed.

Q: Are there official statements about Ferronil's use during pregnancy or breastfeeding?

Official statements confirm that while this medication is commonly used during pregnancy and lactation for prophylaxis or treatment, its use during these periods requires oversight from a healthcare provider.

Q: Does the time of day a person takes Ferronil matter for its effectiveness?

Official dosing instructions focus on the optimal timing relative to meals and other medications, rather than a specific time of day. The goal of these timing rules is to maximize iron absorption, as the drug's effectiveness can be impacted by consumption relative to meals.

Q: Does the official information list any specific contraindications related to allergies?

Regulatory documents list a history of allergic reaction or known hypersensitivity to the drug's components as a formal warning or contraindication. Regulatory documents emphasize the importance of communicating any prior allergic reaction to an iron preparation to a healthcare provider.

How should Ferronil be stored and disposed of?

How to Store and Dispose of Ferronil (Ferrous Carbonate)

Storage and disposal must strictly adhere to regulatory labeling to maintain product stability and ensure safety.


Storage Requirements

Constraint Official Requirement
Temperature Store at room temperature, generally not exceeding 30°C.
Protection Keep the product protected from light, excess heat, and moisture in a dry place.
Container Keep the medicine in its original container and ensure the container is tightly closed.

Child Safety and Disposal

Child-Safety Mandate: Due to the risk of fatal poisoning, all iron-containing products must be stored out of the reach and sight of children at all times.

Disposal: Unused or expired Ferronil must not be thrown away via household waste or wastewater. Consult a pharmacist for proper disposal methods in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferronil found in:

A-Z Index: